clery-ig.frCrawled Nov 5, 2026
Separative designs low-pressure chromatography processes to reduce solvent use and energy consumption.
Cold Pad creates durable composite solutions for high-strength adhesion and fixation.
Cléry’s portfolio includes investments in AgriTech, Chemistry, Energy, Medical, Mobility, Sustainable Packaging, Space, WineTech, and AdEchoTech, which developed a remote ultrasound robot for underserved areas.
AdEchoTech developed a medical robot enabling remote ultrasound examinations for patients in remote or underserved regions.
Cléry invested 5.7 million euros in Hepta Medical to advance ablation techniques for lung cancer and other tumors.
David reflects on his career journey and the values driving Cléry’s sustainable investment model, shared with Robin and the team.
Cléry participated in Primaa’s €5 million fundraising alongside CENITZ and Leia Capital, supporting its AI-driven cancer diagnostics for breast, skin, prostate, and cervical cancers.
Christophe specializes in fundamental analysis of companies, particularly startups.
Eléonore, with 10 years of experience as an Executive Assistant, joined Cléry as Office Manager.
Morgan leads Cléry’s investment projects with a strategy focused on creating durable value.
Cléry’s team combines diverse expertise, including professionals aligned with founders’ backgrounds and new profiles, united by shared values and a focus on meaningful investments.
Stéphanie joined Cléry in 2024 as Office Manager after a decade supporting specialized wealth management firms, overseeing operations, financial data aggregation, and process optimization.
Cléry was founded in 2008 by David Guinard and Robin Ucelli, who met in business school, to launch an entrepreneurial venture in the emerging photovoltaic industry.
Cléry’s investment philosophy prioritizes ethics, impact, and sustainability, aiming for profitability alongside societal benefit.
Cléry invests to drive positive change while seeking long-term financial returns.